YUMC - Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket | Benzinga
Gainers
Cellectis S.A. (NASDAQ: CLLS) shares surged 152% to $2.43 in pre-market trading. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting.
GDEV Inc. (NASDAQ: GDEV) shares rose 26.2% to $2.55 in pre-market trading after falling 11% on Tuesday.
Sientra, Inc. (NASDAQ: SIEN) shares rose 24.7% to $0.7980 in pre-market trading. Sientra shares fell 56% on Tuesday after the company withdrew its FY23 guidance and reported interim third-quarter financial results.
Bruush Oral Care Inc. (NASDAQ: BRSH) rose 16.6% to $0.2751 in pre-market trading after falling 17% on Tuesday.
Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares climbed 15% to $0.9999 in pre-market trading after falling 10% on Tuesday.
NOVONIX Limited (NASDAQ: NVX) shares gained 14.8% to $2.10 in pre-market trading. NOVONIX said its NOVONIX Anode Materials division finalized its $100 million grant award from the U.S. Department of Energy.
Society Pass Incorporated (NASDAQ: SOPA) shares jumped 14.1% to $0.4297 in pre-market trading.
DBV Technologies S.A. ...